Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 2.63M | $ 1.05M | $ 3.09M | $ 2.43M | $ 869.66K |
Total Assets | $ 15.44M | $ 12.50M | $ 13.10M | $ 13.26M | $ 9.74M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 598.54K | $ 406.34K | $ 592.14K | $ 624.62K | $ 865.89K |
Stockholders Equity | $ 14.84M | $ 12.09M | $ 12.51M | $ 12.64M | $ 8.87M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |